# The Realization of a Remote Robotic Breast Surgery

**Authors:** Fujun Shi, Jin Li, Wei Wei, Xiaohua Lin, Lizhen Zhu

PMC · DOI: 10.70352/scrj.cr.25-0607 · Surgical Case Reports · 2026-02-13

## TL;DR

This paper reports the first successful remote robotic breast surgery, showing it is technically feasible and safe in the short term.

## Contribution

The first documented case of remote robotic nipple-sparing mastectomy in breast oncology.

## Key findings

- The surgery achieved R0 resection with minimal blood loss and low network latency.
- The patient recovered without complications, confirming short-term safety.
- The case highlights the potential for remote surgery to improve access to specialized care.

## Abstract

While remote telesurgery has advanced fields like urology and general surgery, its application in breast oncology remains unreported. We present a successful case of remote robotic nipple-sparing mastectomy (rNSM), which preliminarily confirms its technical feasibility and perioperative safety.

A 50-year-old woman with multicentric, HER2-positive early-stage breast cancer accepted rNSM in January 2025. The surgical team operated from Zhujiang Hospital, controlling a single-port robotic system located 60 km away at Foshan Sanshui District People’s Hospital via a dedicated 5G standalone network. The procedure achieved R0 resection with minimal blood loss (<5 mL) and a mean network latency of 4.674 ms. Comprehensive contingency plans for network failure were in place. The patient recovered without complications.

This case preliminarily establishes the technical feasibility and short-term safety of remote breast surgery in a controlled setting. It holds promise for improving access to specialized oncologic care. Future efforts must focus on establishing robust safety protocols, legal frameworks, and evaluating long-term oncological outcomes through larger studies.

## Linked entities

- **Diseases:** breast cancer (MONDO:0004989)

## Full-text entities

- **Genes:** EREG (epiregulin) [NCBI Gene 2069] {aka EPR, ER, Ep}, PGR (progesterone receptor) [NCBI Gene 5241] {aka NR3C3, PR}, ERBB2 (erb-b2 receptor tyrosine kinase 2) [NCBI Gene 2064] {aka CD340, HER-2, HER-2/neu, HER2, MLN 19, MLN-19}, TBX3 (T-box transcription factor 3) [NCBI Gene 6926] {aka TBX3-ISO, UMS, XHL}
- **Diseases:** breast ptosis (MESH:D061325), pain (MESH:D010146), blood (MESH:D006402), cancer (MESH:D009369), PRESENTATION (MESH:D001946), blood loss (MESH:D016063), ductal carcinoma in (MESH:D044584), Breast cancer (MESH:D001943), NSM (MESH:C000626393), axillary lymph node metastasis (MESH:D008207), invasive carcinoma (MESH:D009361), capsular contracture (MESH:D003286)
- **Chemicals:** TCbHP (-), CO2 (MESH:D002245)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12916219/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12916219/full.md

## References

18 references — full list in the complete paper: https://tomesphere.com/paper/PMC12916219/full.md

---
Source: https://tomesphere.com/paper/PMC12916219